Profil
Jan Markus Grimm has worked as a Director at Neurimmune Holding AG since 2020 and is currently employed there.
He has also worked as a Director at AL-S Pharma AG and NovaGo Therapeutics AG, but it is unclear if he is still employed at those companies.
Aktive Positionen von Jan Markus Grimm
| Unternehmen | Position | Beginn |
|---|---|---|
AL-S Pharma AG
 AL-S Pharma AG Pharmaceuticals: MajorHealth Technology AL-S Pharma AG engages in the development and marketing of pharmaceutical products. The company was founded by Michael Salzmann on September 19, 2016 and is headquartered in Schlieren, Switzerland. | Direktor/Vorstandsmitglied | - |
NovaGo Therapeutics AG
 NovaGo Therapeutics AG Pharmaceuticals: MajorHealth Technology NovaGo Therapeutics AG is a biotechnology start-up company, which engages in the development and manufacture of human antibody products. It focuses on cerebral stroke and spinal cord injury to stimulate nerve repair and regeneration. Its offering includes recombinant human monoclonal antibodies targeting the nerve outgrowth inhibitor Nogo-A. The company was founded by Martin E. Schwab and Roger M. Nitsch and is headquartered in Schlieren, Switzerland. | Direktor/Vorstandsmitglied | - |
Neurimmune Holding AG
 Neurimmune Holding AG Pharmaceuticals: MajorHealth Technology Neurimmune Holding AG is a Swiss pharmaceutical company that was founded in 2006. The private company is based in Schlieren, Switzerland and has subsidiaries in Switzerland. Neurimmune Holding manufactures pharmaceutical products. | Direktor/Vorstandsmitglied | 03.02.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Neurimmune Holding AG
Neurimmune Holding AG Pharmaceuticals: MajorHealth Technology Neurimmune Holding AG is a Swiss pharmaceutical company that was founded in 2006. The private company is based in Schlieren, Switzerland and has subsidiaries in Switzerland. Neurimmune Holding manufactures pharmaceutical products. | Health Technology |
AL-S Pharma AG
AL-S Pharma AG Pharmaceuticals: MajorHealth Technology AL-S Pharma AG engages in the development and marketing of pharmaceutical products. The company was founded by Michael Salzmann on September 19, 2016 and is headquartered in Schlieren, Switzerland. | Health Technology |
NovaGo Therapeutics AG
NovaGo Therapeutics AG Pharmaceuticals: MajorHealth Technology NovaGo Therapeutics AG is a biotechnology start-up company, which engages in the development and manufacture of human antibody products. It focuses on cerebral stroke and spinal cord injury to stimulate nerve repair and regeneration. Its offering includes recombinant human monoclonal antibodies targeting the nerve outgrowth inhibitor Nogo-A. The company was founded by Martin E. Schwab and Roger M. Nitsch and is headquartered in Schlieren, Switzerland. | Health Technology |
